BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20150001)

  • 1. Hazelnut consumption decreases the susceptibility of LDL to oxidation, plasma oxidized LDL level and increases the ratio of large/small LDL in normolipidemic healthy subjects.
    Yücesan FB; Orem A; Kural BV; Orem C; Turan I
    Anadolu Kardiyol Derg; 2010 Feb; 10(1):28-35. PubMed ID: 20150001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hazelnut-enriched diet improves cardiovascular risk biomarkers beyond a lipid-lowering effect in hypercholesterolemic subjects.
    Orem A; Yucesan FB; Orem C; Akcan B; Kural BV; Alasalvar C; Shahidi F
    J Clin Lipidol; 2013; 7(2):123-31. PubMed ID: 23415431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hazelnut-enriched diet on plasma cholesterol and lipoprotein profiles in hypercholesterolemic adult men.
    Mercanligil SM; Arslan P; Alasalvar C; Okut E; Akgül E; Pinar A; Geyik PO; Tokgözoğlu L; Shahidi F
    Eur J Clin Nutr; 2007 Feb; 61(2):212-20. PubMed ID: 16969381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol dose and low density lipoprotein heterogeneity in squirrel monkeys (Saimiri sciureus).
    Hojnacki JL; Cluette-Brown JE; Dawson M; Deschenes RN; Mulligan JJ
    Atherosclerosis; 1992 Jun; 94(2-3):249-61. PubMed ID: 1632875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.
    Orem A; Yandi YE; Vanizor B; Cimşit G; Uydu HA; Malkoç M
    Clin Biochem; 2002 May; 35(3):217-24. PubMed ID: 12074830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease.
    Schreier LE; Sanguinetti S; Mosso H; Lopez GI; Siri L; Wikinski RL
    Clin Biochem; 1996 Oct; 29(5):479-87. PubMed ID: 8884071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status.
    Orem C; Orem A; Uydu HA; Celik S; Erdöl C; Kural BV
    Coron Artery Dis; 2002 Feb; 13(1):65-71. PubMed ID: 11917201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
    Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.
    Demirel F; Bideci A; Cinaz P; Camurdan MO; Biberoğlu G; Yesilkaya E; Hasanoğlu A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):129-34. PubMed ID: 17465999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
    Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: a randomized, placebo-controlled trial.
    Homma Y; Ikeda I; Ishikawa T; Tateno M; Sugano M; Nakamura H
    Nutrition; 2003 Apr; 19(4):369-74. PubMed ID: 12679174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF
    Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
    Sanchez-Muniz FJ; Bastida S; Viejo JM; Terpstra AH
    Eur J Nutr; 1999 Feb; 38(1):20-7. PubMed ID: 10338684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
    Walsh BW; Sacks FM
    J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro.
    Tertov VV; Sobenin IA; Kaplun VV; Orekhov AN
    Free Radic Res; 1998 Aug; 29(2):165-73. PubMed ID: 9790519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
    Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
    Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased oxidizability of low-density lipoproteins in hypothyroidism.
    Diekman T; Demacker PN; Kastelein JJ; Stalenhoef AF; Wiersinga WM
    J Clin Endocrinol Metab; 1998 May; 83(5):1752-5. PubMed ID: 9589687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Pitavastatin on Lipoprotein Subfractions and Oxidized Low-density Lipoprotein in Patients with Atherosclerosis.
    Xu RX; Zhang Y; Zhang Y; Wu YR; Li XL; Guo YL; Liu G; Dong Q; Li JJ
    Curr Med Sci; 2020 Oct; 40(5):879-884. PubMed ID: 33123903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.